Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment
Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment
About this item
Full title
Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment
Author / Creator
Publisher
Canada
Journal title
Clinical and investigative medicine, 2016-12, Vol.39 (6), p.27493-27493
Language
English
Formats
Publication information
Publisher
Canada
Subjects
More information
Scope and Contents
Contents
MYC is a transcription factor coding gene that is believed to control 15% of the genes in the entire human genome. The central role of c-MYC in cancer pathogenesis makes it a major therapeutic target in field of anticancer agent development.
We targeted the acetyl-lysine binding modules or bromodomains, which are associated with c-MYC transcript...
Alternative Titles
Full title
Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1846024358
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846024358
Other Identifiers
E-ISSN
1488-2353
